Do you feel like your heart is protected when your cholesterol levels are normal?
Are you immune to heart disease just because you have been informed you have normal cholesterol levels?
If you have been a reader of my articles for any length of time or saw my video about coconut oil and cholesterol, you should know that cholesterol is not the culprit we have all been led to believe.
Half the folks who die of a heart attack never had high cholesterol.
There are other more important markers to consider if you want to know your risk of getting a heart attack or stroke. Again, remember correcting elevated cholesterol does not guarantee immunity from a heart attack. Today, I want you to learn one unappreciated cause of silent coronary artery disease. This silent cause is from a bacteria called Chlamydia.
In fact, 4 out of 5 coronary artery plaques examined contain antibodies to this bug. Chlamydia is a bacterial pathogen that will eat away at your coronary arteries. Tests like C-Reactive Protein (CRPhs) and fibrinogen are indicators of raging inflammation or hidden infection, signaling the need to check for, among other things, Chlamydia.
How do you get Chlamydia?
This bug is a common cause of colds, flu, or bronchitis, and we've all had these. But for some folks, this is not the end of the story, for the coronary plaque can emerge decades after a common cold. Again if you have had coronary artery plaque found from a Heart Scan (calcium score), elevated hsCRP and/or fibrinogen, your next step is to get the antibody test to Chlamydia pneumonia.
The problem is not many doctors including cardiologists are familiar with Chlamydia as a diagnosable and treatable cause of coronary artery plaque. You now have increased knowledge to prevent or minimize your risk of a heart attack or stroke.
Read more about our laboratory testing:
- Linnanmaki E, et al, Chlamydia pneumoniae---Specific Circulating Immune Complexes in Patients with Chronic Coronary Heart Disease, Circulation, 87:1130-34, 1993
- Gupta S, et al, The effect of azithromycin in post-myocardial infarction patients with elevated Chlamydia pneumoniae antibody titers, J Am Coll Cardiol, 29:209a, 1997
- Gupta S, et al, Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction, Circulation, 96:404-07, 1997
- Vojdani A, A look at infectious agents as a possible causative factor in cardiovascular disease: part II, Lab Med, 4; 34: 5-9, April 2003
- Bachmaier K, et al, Chlamydia infections and heart disease linked through antigenic mimicry, Sci, 5406; 283: 1335-39, Feb 26, 1999
- Muhlestrin JB, et al, Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease, J Am Coll Cardiol, 27:1555-61, 1996